Gf Fund Management Co. Ltd. Ascendis Pharma A/S Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,544 shares of ASND stock, worth $263,159. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,544
Previous 1,266
21.96%
Holding current value
$263,159
Previous $174 Million
38.07%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
240Shares Held
59.6MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.72 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$942 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$870 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$759 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$747 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.51B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...